Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Supraciliary wrinkles and botulinum toxin A.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- معلومة اضافية
- المصدر:
Publisher: Oxford University Press Country of Publication: England NLM ID: 7606847 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2230 (Electronic) Linking ISSN: 03076938 NLM ISO Abbreviation: Clin Exp Dermatol Subsets: MEDLINE
- بيانات النشر:
Publication: 2023- : Oxford : Oxford University Press
Original Publication: Oxford : Blackwell Scientific Publications.
- الموضوع:
- نبذة مختصرة :
Background: Injection of botulinum toxin into certain areas of face that carry a high risk of ptosis (danger zone) needs caution in application. An example is the lateral forehead, particularly the lower portion.
Aim: In this study, we evaluated the efficacy and safety of treating supraciliary wrinkles in the lower lateral forehead by injections of botulinum toxin at the temporal hairline, keeping a reasonable distance from danger zone.
Methods: In this randomized clinical trial, 40 women (mean age 35 years) were selected and divided into two groups, A and B. both groups were treated with botulinum toxin to treat wrinkles in the frown area, as well as frontal lines and lateral canthus lines. Group B received extra injections at each temporal line for treatment of supraciliary wrinkles.
Results: There was a significant difference in total wrinkle number and mean number of wrinkles between the two groups after injections (paired t-test, P < 0.01). No ptosis was seen in either group.
Conclusions: Injection of botulinum toxin type A through the temporal hairline to correct supraciliary wrinkles seems to be safe and effective.
- الرقم المعرف:
0 (Neuromuscular Agents)
EC 3.4.24.69 (Botulinum Toxins, Type A)
- الموضوع:
Date Created: 20091031 Date Completed: 20101116 Latest Revision: 20101118
- الموضوع:
20221213
- الرقم المعرف:
10.1111/j.1365-2230.2009.03607.x
- الرقم المعرف:
19874314
No Comments.